Skåne University Hospital is a university hospital in Scania, Sweden. The hospital was founded in 2010 through the merger of the two university hospitals in Lund and Malmö.

During the past decade, Malmo University Hospital MAS conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Malmo University Hospital MAS" are "Prostate Cancer" (1 trials) and "Prostatic Neoplasms" (1 trials). Many other conditions were trialed in "Malmo University Hospital MAS" in a lesser frequency.

Most popular intervention types in "Malmo University Hospital MAS" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Atrasentan" (2 trials). Other intervention names were less common.

The vast majority of trials in "Malmo University Hospital MAS" are 2 trials for "Male" genders.

Currently, there are NaN active trials in "Malmo University Hospital MAS". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Malmo University Hospital MAS, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Malmo University Hospital MAS, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".